1[1]Minno GD. Mancini M. Measuring plasma fibrinogen to predict stroke and myocardial infarction [J]- Ateriosclerosis, 1990, 10: 1-7.
2[2]Acevedo M, Foody JM,Pearce GL, et al. Fibrinogen: associations with cardiovascular events in an outpatient clinic [J]. Am Heart J ,2002,143 (2) :277-282.
3[3]Tanne D. Benderly M ,Goldbourt U ,et al. A prospective study of plasma fibfinogen levels and the risk of stroke among participants in the bezafibrate infarction prevention study [ J ]. Am J Med, 2001,111 (6): 457-463.
4[4]Carter AM, Catto AJ, Bamford LM, et al. Gender-specific associations of the fibrinogen Bβ448.polymorphism, fibrinogen levels, and acute cerebrovascular disease[J]. Arterioscler Thromb Vase Biol, 1997,17:589-594.
5[5]Maat MPM, Knijff P, Green FR, et al. Gender-related association between βfibrinogen genotype and plasma fibrinogen levels and linkage disequilibrium at the fibrinogen locus in Greeland inuit[J]. Arterioscler Thromb Vasc Biol, 1995.15:856-860.
6[6]Humphries SE, Luong LA, Montgomery HE,et al. Gene-environment interaction in the determination of levels of plasma fibrinogen[ J]. Thromb Haemost,1999,82:818-825.
7[7]Levenson J, Giral P, Razavian M, et al. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors [J]. Arterioscler Thromb Vasc Biol,1995,15:1263-1268.
8[8]Maresca G, Blasio AD, Marchioli R, et al. Measuring plasma fibrinogen to predict stroke and myocardial infarction an update [J]. Arterioscler Thromb Vasc Biol, 1999,19:1368-1377.
9[9]Montgomery HE, Clarkaon P, Nwose OM, et al. The acute rise in plasma fibrinogen concentration with exercise is influenced by the G-453-A polymorphism of the β-fibrinogon gene[J]. Arteriosvler Thromb Vaac Biol, 1996,16:386-391.
10[10]Becker RC, Cannon CP, Bovill EG, et al. Prognostic value of plasma fibrinogen concentration in patients with unstable angina and non-Q-wave myocardial infarction (TLMI IIIB Trial)[J]. Am J Cardiol,1996, 78: 142-147.
5Benderly M, Graft E, Reicher RH. Fibrinogen is a predictor of mortality in coronary heart disease patients. The Bezafibrate Infarction Prevention(BIP) Study Group. Arterioseler Thromb Vasc Biol, 1996, 3:351-356.
6Binnie CG. Lord ST. The fibrinogen sequences that interact with throm-bin. Blood, 1993,81:3186.
7Stubbs MT, Oschkinat H, Mary I, et al. The interaetion of thrombin with fibrinogen. Eur J Biochem, 1992,206 : 187.
8Martin PD, Robortson W,Turk D, et al. The structure of residues 7 - 16 of A alpha-chain of human fibrinogen bound to bovine thrombin at 2.3A resolulion. J Biol chem. 1992,267:7911.
9Herrick S,Blanc Brude O ,Gray A,et al. Molecules in focus fibrinogen. Int J Biochem Cell Biol, 1999,31 (7) :741-746.
10Temelkova Kurktschiev T, Koehler C, Henkel E, et al. Leukocyte count and fibrinogen are associated with carotid and femoral intima media thicknessin a risk population for diabetes. Cardiovasc. Res, 2002,56(2) :277:283.
